世界の後天性感染症検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Acquired Infections Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A11683 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、後天性感染症検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。後天性感染症検査の種類別市場規模（疾病検査、薬剤耐性検査）、用途別市場規模（病院、クリニック、外来手術センター（ASC）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・後天性感染症検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gen-Probe、Siemens AG、Alere、Cephei、Roche、Abbott Laboratories、Qiagen GmbH、Becton Dickinson、Meridian Bioscience, Inc.、bioMerieux ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：疾病検査、薬剤耐性検査 ・用途別分析2016年-2026年：病院、クリニック、外来手術センター（ASC）、その他 ・後天性感染症検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・後天性感染症検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・後天性感染症検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・後天性感染症検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・後天性感染症検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Acquired Infections Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Acquired Infections Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Acquired Infections Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Acquired Infections Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Disease Testing
Drug-Resistance Testing

Market segment by Application, can be divided into
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others

Market segment by players, this report covers
Gen-Probe
Siemens AG
Alere
Cephei
Roche
Abbott Laboratories
Qiagen GmbH
Becton Dickinson
Meridian Bioscience, Inc.
bioMerieux

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Acquired Infections Testing
1.2 Classification of Acquired Infections Testing by Type
1.2.1 Overview: Global Acquired Infections Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Acquired Infections Testing Revenue Market Share by Type in 2020
1.2.3 Disease Testing
1.2.4 Drug-Resistance Testing
1.3 Global Acquired Infections Testing Market by Application
1.3.1 Overview: Global Acquired Infections Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Centers (ASC)
1.3.5 Others
1.4 Global Acquired Infections Testing Market Size & Forecast
1.5 Global Acquired Infections Testing Market Size and Forecast by Region
1.5.1 Global Acquired Infections Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Acquired Infections Testing Market Size by Region, (2016-2021)
1.5.3 North America Acquired Infections Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Acquired Infections Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Acquired Infections Testing Market Size and Prospect (2016-2026)
1.5.6 South America Acquired Infections Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Acquired Infections Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acquired Infections Testing Market Drivers
1.6.2 Acquired Infections Testing Market Restraints
1.6.3 Acquired Infections Testing Trends Analysis
2 Company Profiles
2.1 Gen-Probe
2.1.1 Gen-Probe Details
2.1.2 Gen-Probe Major Business
2.1.3 Gen-Probe Acquired Infections Testing Product and Solutions
2.1.4 Gen-Probe Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Gen-Probe Recent Developments and Future Plans
2.2 Siemens AG
2.2.1 Siemens AG Details
2.2.2 Siemens AG Major Business
2.2.3 Siemens AG Acquired Infections Testing Product and Solutions
2.2.4 Siemens AG Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siemens AG Recent Developments and Future Plans
2.3 Alere
2.3.1 Alere Details
2.3.2 Alere Major Business
2.3.3 Alere Acquired Infections Testing Product and Solutions
2.3.4 Alere Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Alere Recent Developments and Future Plans
2.4 Cephei
2.4.1 Cephei Details
2.4.2 Cephei Major Business
2.4.3 Cephei Acquired Infections Testing Product and Solutions
2.4.4 Cephei Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Cephei Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Acquired Infections Testing Product and Solutions
2.5.4 Roche Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 Abbott Laboratories
2.6.1 Abbott Laboratories Details
2.6.2 Abbott Laboratories Major Business
2.6.3 Abbott Laboratories Acquired Infections Testing Product and Solutions
2.6.4 Abbott Laboratories Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Abbott Laboratories Recent Developments and Future Plans
2.7 Qiagen GmbH
2.7.1 Qiagen GmbH Details
2.7.2 Qiagen GmbH Major Business
2.7.3 Qiagen GmbH Acquired Infections Testing Product and Solutions
2.7.4 Qiagen GmbH Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Qiagen GmbH Recent Developments and Future Plans
2.8 Becton Dickinson
2.8.1 Becton Dickinson Details
2.8.2 Becton Dickinson Major Business
2.8.3 Becton Dickinson Acquired Infections Testing Product and Solutions
2.8.4 Becton Dickinson Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Becton Dickinson Recent Developments and Future Plans
2.9 Meridian Bioscience, Inc.
2.9.1 Meridian Bioscience, Inc. Details
2.9.2 Meridian Bioscience, Inc. Major Business
2.9.3 Meridian Bioscience, Inc. Acquired Infections Testing Product and Solutions
2.9.4 Meridian Bioscience, Inc. Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
2.10 bioMerieux
2.10.1 bioMerieux Details
2.10.2 bioMerieux Major Business
2.10.3 bioMerieux Acquired Infections Testing Product and Solutions
2.10.4 bioMerieux Acquired Infections Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 bioMerieux Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acquired Infections Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Acquired Infections Testing Players Market Share
3.2.2 Top 10 Acquired Infections Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Acquired Infections Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acquired Infections Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Acquired Infections Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Acquired Infections Testing Revenue Market Share by Application (2016-2021)
5.2 Acquired Infections Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Acquired Infections Testing Revenue by Type (2016-2026)
6.2 North America Acquired Infections Testing Revenue by Application (2016-2026)
6.3 North America Acquired Infections Testing Market Size by Country
6.3.1 North America Acquired Infections Testing Revenue by Country (2016-2026)
6.3.2 United States Acquired Infections Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Acquired Infections Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Acquired Infections Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Acquired Infections Testing Revenue by Type (2016-2026)
7.2 Europe Acquired Infections Testing Revenue by Application (2016-2026)
7.3 Europe Acquired Infections Testing Market Size by Country
7.3.1 Europe Acquired Infections Testing Revenue by Country (2016-2026)
7.3.2 Germany Acquired Infections Testing Market Size and Forecast (2016-2026)
7.3.3 France Acquired Infections Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Acquired Infections Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Acquired Infections Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Acquired Infections Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acquired Infections Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Acquired Infections Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Acquired Infections Testing Market Size by Region
8.3.1 Asia-Pacific Acquired Infections Testing Revenue by Region (2016-2026)
8.3.2 China Acquired Infections Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Acquired Infections Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Acquired Infections Testing Market Size and Forecast (2016-2026)
8.3.5 India Acquired Infections Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Acquired Infections Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Acquired Infections Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Acquired Infections Testing Revenue by Type (2016-2026)
9.2 South America Acquired Infections Testing Revenue by Application (2016-2026)
9.3 South America Acquired Infections Testing Market Size by Country
9.3.1 South America Acquired Infections Testing Revenue by Country (2016-2026)
9.3.2 Brazil Acquired Infections Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Acquired Infections Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acquired Infections Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Acquired Infections Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Acquired Infections Testing Market Size by Country
10.3.1 Middle East & Africa Acquired Infections Testing Revenue by Country (2016-2026)
10.3.2 Turkey Acquired Infections Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Acquired Infections Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Acquired Infections Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Acquired Infections Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Acquired Infections Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Acquired Infections Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Acquired Infections Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Acquired Infections Testing Revenue Market Share by Region (2021-2026)
Table 6. Gen-Probe Corporate Information, Head Office, and Major Competitors
Table 7. Gen-Probe Major Business
Table 8. Gen-Probe Acquired Infections Testing Product and Solutions
Table 9. Gen-Probe Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siemens AG Corporate Information, Head Office, and Major Competitors
Table 11. Siemens AG Major Business
Table 12. Siemens AG Acquired Infections Testing Product and Solutions
Table 13. Siemens AG Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Alere Corporate Information, Head Office, and Major Competitors
Table 15. Alere Major Business
Table 16. Alere Acquired Infections Testing Product and Solutions
Table 17. Alere Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Cephei Corporate Information, Head Office, and Major Competitors
Table 19. Cephei Major Business
Table 20. Cephei Acquired Infections Testing Product and Solutions
Table 21. Cephei Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Acquired Infections Testing Product and Solutions
Table 25. Roche Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Abbott Laboratories Major Business
Table 28. Abbott Laboratories Acquired Infections Testing Product and Solutions
Table 29. Abbott Laboratories Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Qiagen GmbH Corporate Information, Head Office, and Major Competitors
Table 31. Qiagen GmbH Major Business
Table 32. Qiagen GmbH Acquired Infections Testing Product and Solutions
Table 33. Qiagen GmbH Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 35. Becton Dickinson Major Business
Table 36. Becton Dickinson Acquired Infections Testing Product and Solutions
Table 37. Becton Dickinson Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Meridian Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Meridian Bioscience, Inc. Major Business
Table 40. Meridian Bioscience, Inc. Acquired Infections Testing Product and Solutions
Table 41. Meridian Bioscience, Inc. Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. bioMerieux Corporate Information, Head Office, and Major Competitors
Table 43. bioMerieux Major Business
Table 44. bioMerieux Acquired Infections Testing Product and Solutions
Table 45. bioMerieux Acquired Infections Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Acquired Infections Testing Revenue (USD Million) by Players (2019-2021)
Table 47. Global Acquired Infections Testing Revenue Share by Players (2019-2021)
Table 48. Breakdown of Acquired Infections Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Acquired Infections Testing Players Head Office, Products and Services Provided
Table 50. Acquired Infections Testing Mergers & Acquisitions in the Past Five Years
Table 51. Acquired Infections Testing New Entrants and Expansion Plans
Table 52. Global Acquired Infections Testing Revenue (USD Million) by Type (2016-2021)
Table 53. Global Acquired Infections Testing Revenue Share by Type (2016-2021)
Table 54. Global Acquired Infections Testing Revenue Forecast by Type (2021-2026)
Table 55. Global Acquired Infections Testing Revenue by Application (2016-2021)
Table 56. Global Acquired Infections Testing Revenue Forecast by Application (2021-2026)
Table 57. North America Acquired Infections Testing Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Acquired Infections Testing Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Acquired Infections Testing Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Acquired Infections Testing Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Acquired Infections Testing Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Acquired Infections Testing Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Acquired Infections Testing Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Acquired Infections Testing Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Acquired Infections Testing Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Acquired Infections Testing Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Acquired Infections Testing Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Acquired Infections Testing Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Acquired Infections Testing Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Acquired Infections Testing Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Acquired Infections Testing Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Acquired Infections Testing Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Acquired Infections Testing Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Acquired Infections Testing Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Acquired Infections Testing Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Acquired Infections Testing Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Acquired Infections Testing Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Acquired Infections Testing Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Acquired Infections Testing Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Acquired Infections Testing Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Acquired Infections Testing Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Acquired Infections Testing Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Acquired Infections Testing Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Acquired Infections Testing Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Acquired Infections Testing Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Acquired Infections Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Acquired Infections Testing Picture
Figure 2. Global Acquired Infections Testing Revenue Market Share by Type in 2020
Figure 3. Disease Testing
Figure 4. Drug-Resistance Testing
Figure 5. Acquired Infections Testing Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Ambulatory Surgery Centers (ASC) Picture
Figure 9. Others Picture
Figure 10. Global Acquired Infections Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Acquired Infections Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Acquired Infections Testing Revenue Market Share by Region (2016-2026)
Figure 13. Global Acquired Infections Testing Revenue Market Share by Region in 2020
Figure 14. North America Acquired Infections Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Acquired Infections Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Acquired Infections Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Acquired Infections Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Acquired Infections Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Acquired Infections Testing Market Drivers
Figure 20. Acquired Infections Testing Market Restraints
Figure 21. Acquired Infections Testing Market Trends
Figure 22. Gen-Probe Recent Developments and Future Plans
Figure 23. Siemens AG Recent Developments and Future Plans
Figure 24. Alere Recent Developments and Future Plans
Figure 25. Cephei Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Abbott Laboratories Recent Developments and Future Plans
Figure 28. Qiagen GmbH Recent Developments and Future Plans
Figure 29. Becton Dickinson Recent Developments and Future Plans
Figure 30. Meridian Bioscience, Inc. Recent Developments and Future Plans
Figure 31. bioMerieux Recent Developments and Future Plans
Figure 32. Global Acquired Infections Testing Revenue Share by Players in 2020
Figure 33. Acquired Infections Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Acquired Infections Testing Revenue Market Share in 2020
Figure 35. Global Top 10 Players Acquired Infections Testing Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Acquired Infections Testing Revenue Share by Type in 2020
Figure 38. Global Acquired Infections Testing Market Share Forecast by Type (2021-2026)
Figure 39. Global Acquired Infections Testing Revenue Share by Application in 2020
Figure 40. Global Acquired Infections Testing Market Share Forecast by Application (2021-2026)
Figure 41. North America Acquired Infections Testing Sales Market Share by Type (2016-2026)
Figure 42. North America Acquired Infections Testing Sales Market Share by Application (2016-2026)
Figure 43. North America Acquired Infections Testing Revenue Market Share by Country (2016-2026)
Figure 44. United States Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Acquired Infections Testing Sales Market Share by Type (2016-2026)
Figure 48. Europe Acquired Infections Testing Sales Market Share by Application (2016-2026)
Figure 49. Europe Acquired Infections Testing Revenue Market Share by Country (2016-2026)
Figure 50. Germany Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Acquired Infections Testing Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Acquired Infections Testing Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Acquired Infections Testing Revenue Market Share by Region (2016-2026)
Figure 58. China Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Acquired Infections Testing Sales Market Share by Type (2016-2026)
Figure 65. South America Acquired Infections Testing Sales Market Share by Application (2016-2026)
Figure 66. South America Acquired Infections Testing Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Acquired Infections Testing Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Acquired Infections Testing Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Acquired Infections Testing Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Acquired Infections Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---